Why 2026 matters for EU Joint Clinical Assessment readiness
As we move into 2026, EU Joint Clinical Assessments (JCAs) are shifting from policy concept to operational[…]
EU JCA 2025 Explained: What Rare Disease Sponsors Need to Know Now
The EU Joint Clinical Assessment (JCA) is one of the most significant changes to hit market access in years.[…]